CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹899 Cr | ₹804 Cr | ₹786 Cr | ₹869 Cr | ₹706 Cr |
What is the latest Total Non-Current Assets ratio of CONCORD BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹899 Cr |
| Mar2024 | ₹804 Cr |
| Mar2023 | ₹786 Cr |
| Mar2022 | ₹869 Cr |
| Mar2021 | ₹706 Cr |
How is Total Non-Current Assets of CONCORD BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹899 Cr | 11.75 | |
| Mar2024 | ₹804 Cr | 2.31 | |
| Mar2023 | ₹786 Cr | -9.54 | |
| Mar2022 | ₹869 Cr | 23.19 | |
| Mar2021 | ₹706 Cr | - | |
Compare Total Non-Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,926.5 Cr | -6.9% | -15.3% | -40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -6.9% |
-15.3% |
-40.6% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses